Brooklyn ImmunoTherapeutics (BTX) Dividend Yield, Date & History $7.31 -0.01 (-0.14%) As of 03:59 PM Eastern Add Share Share Dividend Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsTrendsBuy This Stock Brooklyn ImmunoTherapeutics Dividend SummaryDividend Yield12.86%Annual Dividend$0.94Recent Dividend Payment Mar. 31 Dividend Payout Ratio -41.41% Brooklyn ImmunoTherapeutics (BTX) pays an annual dividend of $0.94 per share, with a dividend yield of 12.86%. The most recent n/a payment of $0.0862 per share was paid on Monday, March 31, to investors who owned the stock before the ex-dividend date of Friday, March 14. The company currently pays out -41.41% of its earnings as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryBTX Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Brooklyn ImmunoTherapeutics' dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Brooklyn ImmunoTherapeutics in Dividend Calculator BTX Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Brooklyn ImmunoTherapeutics' dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Brooklyn ImmunoTherapeutics in Dividend Yield Calculator Brooklyn ImmunoTherapeutics vs. The CompetitionCompare Brooklyn ImmunoTherapeutics' annual dividend, yield, and 3-year growth rate with averages for and NYSE companies to evaluate its performance against the market.TypeBrooklyn ImmunoTherapeutics CompaniesNYSE CompaniesAnnual Dividend$0.94$0.02$1.58Dividend Yield12.86%13.61%3.64%Annualized 3-Year Dividend Growth0.00%0.00%0.00%Brooklyn ImmunoTherapeutics Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings-41.41% Brooklyn ImmunoTherapeutics Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame Start Date End Date Export to Excel AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date3/3/2025monthly$0.0862 - 3/14/20253/14/20253/31/2025This table shows Brooklyn ImmunoTherapeutics' dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Brooklyn ImmunoTherapeutics Dividend - Frequently Asked Questions What is Brooklyn ImmunoTherapeutics' dividend yield? The current dividend yield for Brooklyn ImmunoTherapeutics is 12.86%. Learn more on BTX's dividend yield history. How much is Brooklyn ImmunoTherapeutics' annual dividend? The annual dividend for BTX shares is $0.94. Learn more on BTX's annual dividend history. How often does Brooklyn ImmunoTherapeutics pay dividends? Brooklyn ImmunoTherapeutics pays n/a dividends to shareholders. What is Brooklyn ImmunoTherapeutics' dividend payout ratio? The dividend payout ratio for BTX is: -41.41% based on the trailing year of earnings Is Brooklyn ImmunoTherapeutics a good dividend stock? Brooklyn ImmunoTherapeutics' dividend yield of 0.00% is lower than the average company that issues a dividend. More Dividend Resources from MarketBeat Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade SaleIs Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?Analysts See Upside in These 5 Stocks That Just Raised DividendsJPMorgan Q2 Results Affirm Dividend, Buybacks, & GrowthDon’t Miss These 4 Stocks With Explosive Dividend Yields4 Stocks Lift Dividends As Much as 33% As Banks Pass Stress TestsWhy the Schwab Dividend ETF Rallied—and Can It Keep Climbing?3 Dividend Kings Trading at Rare Discounts to Buy This SummerTop International ETFs With Dividends and Market-Beating Returns More Dividend News This page (NYSE:BTX) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!99.8% voted YES on this crypto partnership Kraken—one of the world's biggest crypto exchanges—just picked O...Crypto 101 Media | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.